🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Study to establish the relative bioavailability of the TPV oral solution fo...
Status
Completed
Location
Multiple Locations
Start Date
2006-02
Trial ID
NCT02227017
Treatments Being Tested
The purpose of this study is to characterise the pharmacokinetic profiles o...
Status
Completed
Location
Germans Trias i Pujol Hospital
Start Date
2005-01
Trial ID
NCT00307502
A prospective, multi-center, non-randomized interventional study to evaluat...
Status
Recruiting
Location
Venusmedtech of America
Start Date
2024-06-11
Trial ID
NCT06010563
Treatments Being Tested
The objective of this study is to establish the tipranavir-ritonavir steady...
Status
Completed
Location
Multiple Locations
Start Date
2000-10
Trial ID
NCT02251132
To determine the effect of steady-state tipranavir 500 mg/ritonavir 200 mg ...
Status
Terminated
Location
Multiple Locations
Start Date
2006-08
Trial ID
NCT02229760
Treatments Being Tested
Study to determine the relative bioavailability of 500/200 mg of tipranavir...
Status
Completed
Location
Multiple Locations
Start Date
2003-10
Trial ID
NCT02251158
The primary purpose of this study is to: 1. Demonstrate the safety and eff...
Status
Terminated
Location
1182.98.033 Boehringer Ingelheim Investigational Site
Start Date
2007-02
Trial ID
NCT00440271
Treatments Being Tested
Study to characterise the effects of concurrent tipranavir (TPV) and ritona...
Status
Completed
Location
Multiple Locations
Start Date
2001-09
Trial ID
NCT02251873
Treatments Being Tested
Primary: To quantify the influence of single-dose and steady-state tipranav...
Status
Completed
Location
Multiple Locations
Start Date
2006-01
Trial ID
NCT02243553